Buy or sell Finch Therapeutics Group stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Finch Therapeutics Group Stock

Finch Therapeutics Group is a microbiome therapeutics company, develops microbial therapies serving patients with serious.

About Finch Therapeutics Group Stock

Finch Therapeutics, a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. Founded by data scientists, clinicians, and microbiologists from MIT and OpenBiome, Finch uses machine- learning algorithms informed by high-throughput molecular data to reverse engineer successful clinical experience with fecal transplantation.

Funding History

December 2016$5.6M
March 2018$36.0M

Management

CEO

MARK SMITH

CFO

Greg Perry

CMO

KIRK TAYLOR

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Finch Therapeutics Group or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 110K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo